Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4626571000168119 | Jorveza (budesonide 500 microgram) orally disintegrating tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4626581000168116 | Jorveza 500 microgram orally disintegrating tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Jorveza 500 microgram orally disintegrating tablet | Is a | Jorveza | true | Inferred relationship | Some | ||
| Jorveza 500 microgram orally disintegrating tablet | Is a | budesonide 500 microgram orally disintegrating tablet | true | Inferred relationship | Some | ||
| Jorveza 500 microgram orally disintegrating tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Jorveza 500 microgram orally disintegrating tablet | has manufactured dose form | orally disintegrating tablet | true | Inferred relationship | Some | ||
| Jorveza 500 microgram orally disintegrating tablet | has unit of use | tablet | true | Inferred relationship | Some | 1325207480 | |
| Jorveza 500 microgram orally disintegrating tablet | has Australian BoSS | budesonide | true | Inferred relationship | Some | 724803311 | |
| Jorveza 500 microgram orally disintegrating tablet | has intended active ingredient | budesonide | true | Inferred relationship | Some | 724803311 |
Reference Sets
Trade product unit of use reference set
FHIR